BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05203445-completion@plaintrial.com
DTSTAMP:20260926T110627Z
DTSTART;VALUE=DATE:202701
SUMMARY:A Study of Olaparib and Pembrolizumab in People With Triple Negativ
 e Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast C
 ancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05203445
URL:https://plaintrial.com/trial/NCT05203445
END:VEVENT
END:VCALENDAR